CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Policies to Expand Naloxone Availability: A Review of the Clinical Effectiveness

Last updated: September 23, 2014
Project Number: RA0697-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Reference List
Result type: Report

Question

  1. What is the effectiveness of policies to increase the availability of naloxone to opioid users?

Key Message

One systematic review and two non-randomized studies regarding the effectiveness of policies to increase the availability of naloxone to opioid users were identified.